Cargando…
Evaluation of intraductal delivery of poly(ethylene glycol)‐doxorubicin conjugate nanocarriers for the treatment of ductal carcinoma in situ (DCIS)‐like lesions in rats
Ductal carcinoma in situ is the most commonly diagnosed early stage breast cancer. The efficacy of intraductally delivered poly(ethylene glycol)‐doxorubicin (PEG‐DOX) nanocarriers, composed of one or more DOX conjugated to various PEG polymers, was investigated in an orthotopic ductal carcinoma in s...
Autores principales: | Gu, Zichao, Al‐Zubaydi, Firas, Adler, Derek, Li, Shike, Johnson, Steven, Prasad, Puja, Holloway, Jennifer, Szekely, Zoltan, Love, Susan, Gao, Dayuan, Sinko, Patrick J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220801/ https://www.ncbi.nlm.nih.gov/pubmed/30443411 http://dx.doi.org/10.1002/jin2.51 |
Ejemplares similares
-
Intraductal therapy of DCIS with liposomal doxorubicin: a preoperative trial in rural California
por: Mahoney, ME, et al.
Publicado: (2009) -
Mouse‐INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy
por: Hong, Yan, et al.
Publicado: (2021) -
Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002) -
Simulation of Doxorubicin Delivery via Glucosamine(ethylene glycol) Carrier
por: Pirawattana, Thongjun, et al.
Publicado: (2008) -
Status of Intraductal Therapy for Ductal Carcinoma in Situ
por: Flanagan, Meghan, et al.
Publicado: (2010)